NCT00660361 A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients Status UNKNOWN Phase N/A
NCT00650949 Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT00648817 Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers Status COMPLETED Phase PHASE4
NCT00647946 Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue Status COMPLETED Phase PHASE2
NCT00645736 CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study Status COMPLETED Phase N/A
NCT00645294 Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV Status COMPLETED Phase PHASE1/PHASE2
NCT00644761 PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients Status COMPLETED Phase PHASE2
NCT00644332 An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041) Status COMPLETED Phase PHASE4
NCT00643968 Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial Status COMPLETED Phase PHASE4
NCT00642291 An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects Status COMPLETED Phase PHASE2
NCT00617305 Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) Status COMPLETED Phase PHASE4
NCT00615810 ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial Status COMPLETED Phase PHASE4
NCT00615745 ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla Status COMPLETED Phase PHASE4
NCT00603863 Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00603668 Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL Status COMPLETED Phase PHASE1/PHASE2
NCT00597129 Safety and Efficacy Study of 90Y-hPAM4 at Different Doses Status COMPLETED Phase PHASE1/PHASE2
NCT00596804 Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00578786 A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202) Status COMPLETED Phase PHASE3